Tevogen Bio Holdings (TVGN) said late Friday that it broadened its relationship with Microsoft (MSFT) to expand its artificial intelligence-focused collaboration while building a technology designed to help with predictive precision T-cell targeting.
Shares of Tevogen advanced 30% as intraday trading volume soared to more than 48.5 million from a daily average of about 2.9 million.
Aurora Mobile (JG) said Monday that its business-oriented AI agent platform GPTBots.ai integrated the DeepSeek R1 large language model.
Shares skyrocketed 166% as intraday trading volume surged to over 28.5 million from a daily average of about 15,000.
Akero Therapeutics (AKRO) said Monday a phase 2b study of its lead product candidate, efruxifermin, showed a "statistically significant" reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH.
Shares surged more than 91% as intraday trading volume catapulted to over 11.7 million from a daily average of about 723,000.
Price: 1.75, Change: +0.40, Percent Change: +29.70
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.